Feasibility of selective cardiac ventricular electroporation.

Alan M SugrueVaibhav R VaidyaChristopher LiviaDeepak PadmanabhanAnas AbudanAmeesh IsathTyra WittChristopher V DeSimonePaul StalboergerSuraj KapaSamuel J AsirvathamChristopher J McLeod

Published in: PloS one (2020)

PEF provides a novel, safe method for non-thermal acute modulation of the Purkinje fibers without significant injury to the underlying myocardium. Future optimization of this energy delivery is required to optimize conditions so that selective electroporation can be utilized in humans the treatment of cardiac disease.

Keyphrases

left ventricular
liver failure
heart failure
drug induced
intensive care unit
aortic dissection
combination therapy
hepatitis b virus
replacement therapy